Effects of Common Antitussive Drugs on the hERG Potassium Channel Current

被引:20
|
作者
Deisemann, Heike [1 ]
Ahrens, Nadine [1 ]
Schlobohm, Irene [1 ]
Kirchhoff, Christian [1 ]
Netzer, Rainer [1 ]
Moeller, Clemens [1 ]
机构
[1] Evotec AG, D-22525 Hamburg, Germany
关键词
antitussive; clobutinol; hERG; QT prolongation; torsade de pointes;
D O I
10.1097/FJC.0b013e31818eec8d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A common over-the-counter (OTC) non-opioid antitussive drug, clobutinol, was recently withdrawn from the market due to its potential to induce cardiac arrhythmias by a blockade of the potassium channel coded by the human ether-a-go-go-related gene (hERG). In this study, we investigated the effects of a number of antitussive compounds on the hERG ion channel current using patch-clamp electrophysiology, and compared the effects to that of clobutinol. The compounds clobutinol, pentoxyverine, dextromethorphan, and codeine inhibited the outward current in hERG transfected cells with half-maximal inhibition concentrations (IC50) of 1-9 mu M, 3.0 mu M, 5.1 mu M, and 97 mu M, respectively. For the obromine, no significant effect on the hERG current at a concentration up to 100 mu M was detected. Safety margins between the effects of the drugs on the hERG ion channel current and their calculated maximal free therapeutic plasma concentration were calculated. These results were compared to assess potential risks of the compounds to induce torsade de pointes-type arrhythmias.
引用
收藏
页码:494 / 499
页数:6
相关论文
共 50 条
  • [1] Modeling hERG and its interactions with drugs: Recent advances in light of current potassium channel simulations
    Recanatini, Maurizio
    Cavalli, Andrea
    Masetti, Matteo
    CHEMMEDCHEM, 2008, 3 (04) : 523 - 535
  • [2] Modulation by testosterone of an endogenous hERG potassium channel current
    Ridley, J. M.
    Shuba, Y. M.
    James, A. F.
    Hancox, J. C.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2008, 59 (03): : 395 - 407
  • [3] The Effects of Extracellular Protons on the hERG Potassium Channel
    Wilson, Stacey L.
    Marrion, Neil V.
    Hancox, Jules C.
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 410A - 410A
  • [4] The effects of liquiritigenin on the activity of the hERG potassium channel
    Sweeney, O.
    Wang, T.
    Ellory, C.
    Wilkins, R.
    Ma, Y.
    BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (16) : 3067 - 3068
  • [5] Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel
    Mergenthaler, J
    Haverkamp, W
    Hüttenhofer, A
    Skryabin, BV
    Musshoff, U
    Borggrefe, M
    Speckmann, EJ
    Breithardt, G
    Madeja, M
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2001, 363 (04) : 472 - 480
  • [6] Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel
    Scott J.C. Stanat
    Carol G. Carlton
    William J. Crumb
    Krishna C. Agrawal
    Craig W. Clarkson
    Molecular and Cellular Biochemistry, 2003, 254 : 1 - 7
  • [7] Blocking effects of the antiarrhythmic drug propafenone on the HERG potassium channel
    Jörg Mergenthaler
    Wilhelm Haverkamp
    Alexander Hüttenhofer
    Boris V. Skryabin
    Ulrich Mußhoff
    Martin Borggrefe
    Erwin-Josef Speckmann
    Günter Breithardt
    Michael Madeja
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2001, 363 : 472 - 480
  • [8] Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel
    Stanat, SJC
    Carlton, CG
    Crumb, WJ
    Agrawal, KC
    Clarkson, CW
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 254 (1-2) : 1 - 7
  • [9] Effects of changes in extracellular pH and potassium concentration on hERG current
    Yu, WG
    Kimura, K
    Noguchi, E
    Ma, CJ
    Watanabe, N
    Yamaguchi, M
    Imaizumi, M
    Atai, H
    Nishi, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 236P - 236P
  • [10] The hERG potassium channel as a therapeutic target
    Witchel, Harry J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (03) : 321 - 336